Insulin Resistance: The Earliest Signs and How to Reverse It

Insulin resistance is the state in which your muscle, liver and fat cells respond poorly to insulin, so your pancreas has to pump out more of it to keep blood glucose normal. It is the slow-burning engine behind most type 2 diabetes, and it usually develops silently for a decade or more before blood sugar ever drifts out of range. The good news is that it is largely reversible: the same levers that prevent type 2 diabetes (losing visceral fat, building and using muscle, sleeping properly) can restore insulin sensitivity, and the effect sizes from controlled trials are genuinely large.

What insulin resistance actually is

After you eat, your pancreas releases insulin to move glucose out of the blood and into cells, and to switch off the liver's own glucose production. When tissues stop listening to that signal, the body's first response is not high blood sugar: it is more insulin. The pancreas compensates, blood glucose stays normal, and you feel completely fine. This compensated phase, marked by high circulating insulin (hyperinsulinaemia) with normal glucose, is insulin resistance.¹

This is the part most people get wrong. Insulin resistance is not the same as diabetes, and it is not diagnosed by a normal blood-sugar test. Type 2 diabetes only appears later, when the pancreas can no longer keep up and glucose finally rises. By the time a standard HbA1c crosses into the diabetic range, the underlying resistance has often been present, and worsening, for years.¹

Why it precedes diabetes by years

The clearest picture of this timeline comes from the Whitehall II study, a long-running cohort of British civil servants. Analysing 6,538 people followed for a median of about ten years, Adam Tabak and colleagues mapped what happened in the run-up to 505 new diabetes diagnoses. Working backwards from diagnosis, they could see fasting glucose, insulin sensitivity and insulin secretion all changing measurably 3 to 6 years before anyone was diagnosed, with insulin sensitivity falling steeply in the final years.⁶ Other longitudinal work suggests the very earliest declines in insulin sensitivity can begin a decade or more before diabetes appears.⁶

That long lead time is the whole point of this article. It is also the opportunity. For years before any conventional test flags a problem, the body is sending quieter signals, if you know which ones to look at.

The early markers most people miss

A standard NHS check usually measures HbA1c or fasting glucose. Both are lagging indicators: they stay normal during the compensated, high-insulin phase and only move once the pancreas is already struggling. To see resistance earlier, you need markers that reflect insulin itself, or the metabolic consequences of too much of it.

Of these, HOMA-IR (calculated as fasting insulin in mIU/L multiplied by fasting glucose in mmol/L, divided by 22.5) is the most studied research surrogate, and the triglyceride-to-HDL ratio is the most accessible, because it can be read off a routine lipid panel you may already have.⁷ A useful caveat: the triglyceride-to-HDL ratio performs less well in people of Black African ancestry, so it is a screen, not a verdict.⁷ The single most important point is to read these as a trajectory. A fasting insulin creeping up year on year, or a triglyceride-to-HDL ratio climbing while your waist expands, tells you more than any one snapshot. If you are tracking your own numbers, our guide to reading your labs in context may help, and the stack builder can map markers to candidate interventions.

What actually drives it

The dominant driver in most people is not sugar per se, nor carbohydrates in isolation. It is fat stored in the wrong places. When subcutaneous fat (the fat under the skin) reaches the limit it can safely hold, often called a personal fat threshold, surplus energy spills over into the liver, pancreas and muscle as ectopic fat. That ectopic fat interferes with insulin signalling locally, a process termed lipotoxicity, which is why visceral and liver fat track so closely with insulin resistance.⁸

This explains several things that puzzle people. It is why some slim individuals are insulin resistant (a low personal fat threshold), why BMI alone is a blunt instrument, and why losing a relatively modest amount of weight, if it comes from the liver and pancreas first, can produce a disproportionately large metabolic improvement. It also reframes the role of diet: the strongest dietary lever is whatever sustainably reduces that ectopic fat, which usually means an energy deficit, not a particular macronutrient.⁸ Other genuine contributors include physical inactivity (muscle is the main site of glucose disposal), poor sleep, and chronic stress, which we cover in the wider hormones library.

The evidence-based levers to reverse it

Here is the honest hierarchy, with effect sizes where the trials allow. The unglamorous foundations beat everything sold as a shortcut.

1. Lose visceral and liver fat

This is the single most powerful lever. In the US Diabetes Prevention Program (3,234 adults with prediabetes, published in the New England Journal of Medicine in 2002), a programme targeting 7 percent weight loss plus 150 minutes a week of activity cut the incidence of type 2 diabetes by 58 percent over an average of 2.8 years, beating metformin, which cut it by 31 percent.³ In the UK DiRECT trial (Roy Taylor, Mike Lean and colleagues, The Lancet, 2018), a structured low-calorie programme in routine primary care achieved diabetes remission in 46 percent of participants at one year; among those who lost 15 kg or more, remission reached roughly 86 percent.⁴ Remission rates fell over time as some weight returned (about 36 percent at two years), which is the honest caveat: maintenance is the hard part.⁴

2. Resistance training plus zone 2 cardio

Exercise improves insulin sensitivity through two distinct routes. Acutely, contracting muscle pulls glucose in by an insulin-independent pathway (GLUT4 transporters moving to the cell surface), and the resulting improvement in insulin action can last 24 to 48 hours after a single session.⁵ Chronically, building muscle expands the tissue available to soak up glucose. A meta-analysis of 27 studies in adults with overweight or obesity without diabetes found resistance training reduced HOMA-IR with a mean difference of about -1.05.⁹ Effects in older adults are real but smaller (one meta-analysis of 12 RCTs reported a standardised effect of about -0.25 on HOMA-IR and -0.51 on HbA1c).⁹ The practical reading: combine resistance training (for muscle mass) with regular moderate aerobic work such as zone 2 (for the acute, sensitising effect), most days.

3. Protect your sleep

Sleep is an underrated metabolic lever. In a tightly controlled study by Buxton and colleagues, restricting sleep for a week lowered whole-body insulin sensitivity in healthy men; an earlier laboratory study found about a 16 percent fall in total-body insulin response and a 30 percent fall in fat-cell insulin sensitivity after just four nights of short sleep.¹⁰ These are small, short experiments, so do not over-read the exact percentages, but the direction is consistent across studies. Chronically curtailed sleep nudges you toward insulin resistance.

4. Diet composition and meal timing

Two honest points here. First, for reversing insulin resistance, total energy and the resulting fat loss matter more than the low-carb-versus-low-fat argument. A meta-analysis of randomised trials in type 2 diabetes found low-carbohydrate diets gave a short-term edge in HbA1c and weight (around 3 kg more loss), but the advantage largely faded by 12 to 24 months, leaving the two approaches broadly comparable long term.¹¹ Pick the pattern you can sustain. Second, time-restricted eating is widely promoted but the evidence is modest and mixed: meta-analyses show small, consistent improvements in fasting glucose and HbA1c in people with type 2 diabetes or prediabetes, while several controlled trials found no improvement in insulin sensitivity specifically beyond what weight loss explains.¹²

What to ask your GP

What to do next

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.